Page last updated: 2024-11-04

sulfasalazine and Serum Sickness

sulfasalazine has been researched along with Serum Sickness in 2 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Serum Sickness: Immune complex disease caused by the administration of foreign serum or serum proteins and characterized by fever, lymphadenopathy, arthralgia, and urticaria. When they are complexed to protein carriers, some drugs can also cause serum sickness when they act as haptens inducing antibody responses.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Delage, C1
Lagacé, R1
Brooks, H1
Taylor, HG1
Nichol, FE1

Other Studies

2 other studies available for sulfasalazine and Serum Sickness

ArticleYear
[Serum sickness with pseudolymphomatous lymph node hyperplasia caused by salicylazosulfapyridine].
    L'union medicale du Canada, 1975, Volume: 104, Issue:4

    Topics: Adult; Colitis, Ulcerative; Humans; Lymphatic Diseases; Male; Serum Sickness; Sulfasalazine

1975
The three week sulphasalazine syndrome.
    Clinical rheumatology, 1992, Volume: 11, Issue:4

    Topics: Arthritis, Rheumatoid; Chemical and Drug Induced Liver Injury; Humans; Male; Middle Aged; Prednisolo

1992